Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

TCT-436 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study.

Nef H, Hauptmann KE, Latib A, Morrison L, Toyloy S, Vandertie L, Colombo A.

J Am Coll Cardiol. 2016 Nov 1;68(18S):B176. doi: 10.1016/j.jacc.2016.09.571. No abstract available.

PMID:
27969790
2.

Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.

Lefèvre T, Colombo A, Tchétché D, Latib A, Klugmann S, Fajadet J, De Marco F, Maisano F, Bruschi G, Bijuklic K, Nava S, Weissman N, Low R, Thomas M, Young C, Redwood S, Mullen M, Yap J, Grube E, Nickenig G, Sinning JM, Hauptmann KE, Friedrich I, Lauterbach M, Schmoeckel M, Davidson C, Schofer J.

JACC Cardiovasc Interv. 2016 Jan 11;9(1):68-75. doi: 10.1016/j.jcin.2015.09.027.

3.

Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial.

Costa RA, Abizaid A, Mehran R, Schofer J, Schuler GC, Hauptmann KE, Magalhães MA, Parise H, Grube E; BioFreedom FIM Clinical Trial Investigators..

JACC Cardiovasc Interv. 2016 Jan 11;9(1):51-64. doi: 10.1016/j.jcin.2015.09.008.

4.

Reducing Patient Radiation Dose With Image Noise Reduction Technology in Transcatheter Aortic Valve Procedures.

Lauterbach M, Hauptmann KE.

Am J Cardiol. 2016 Mar 1;117(5):834-8. doi: 10.1016/j.amjcard.2015.12.016.

PMID:
26742472
5.

Transcatheter valve-in-ring implantation of a repositionable valve system for treatment of severe mitral regurgitation.

Lauterbach M, Sontag B, Paraforos A, Friedrich I, Hauptmann KE.

Catheter Cardiovasc Interv. 2016 Nov 15;88(6):E183-E190. doi: 10.1002/ccd.26376.

PMID:
26700547
6.

Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis.

Sedaghat A, von Dobbeler C, Sontag B, Sinning JM, Fimmers R, Mellert F, Schiller W, Welz A, Grube E, Nickenig G, Hauptmann KE, Werner N.

EuroIntervention. 2015 Oct;11(6):698-704. doi: 10.4244/EIJY15M01_10.

7.

Fifteen-year experience with carotid artery stenting (from the carotid artery stenting-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte).

Werner N, Zeymer U, Hochadel M, Hauptmann KE, Jung J, Janicke I, Haase H, Leschke M, Mudra H, Zahn R; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte, Rheinland-Pfalz, Germany..

Am J Cardiol. 2015 Feb 1;115(3):360-6. doi: 10.1016/j.amjcard.2014.11.009.

PMID:
25498539
8.

Mechanism of luminal patency of the self-expanding Sideguard sidebranch stent: evaluation by intravascular ultrasound and optical coherence tomography.

Ma S, Maehara A, Hauptmann KE, Guagliumi G, Valsecchi O, Vassileva AN, Appelman Y, Sangiorgi G, Prati F, Mintz GS.

Catheter Cardiovasc Interv. 2014 Nov 1;84(5):734-41. doi: 10.1002/ccd.25582.

PMID:
24948549
9.

Evaluation of oral anticoagulation therapy: rationale and design of the thrombEVAL study programme.

Prochaska JH, Coldewey M, Göbel S, Keller K, Hendelmeier M, Konstantinides S, Münzel T, Wild PS; thrombEVAL Study Group..

Eur J Prev Cardiol. 2015 May;22(5):622-8. doi: 10.1177/2047487314527852.

PMID:
24685605
10.

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.

Camenzind E, Boersma E, Wijns W, Mauri L, Rademaker-Havinga T, Ordoubadi FF, Suttorp MJ, Al Kurdi M, Steg PG; PROTECT Steering Committee and Investigators..

Eur Heart J. 2014 Aug 1;35(29):1932-48. doi: 10.1093/eurheartj/ehu084.

11.

Use of drug-eluting stents in acute myocardial infarction with persistent ST-segment elevation: results of the ALKK PCI-registry.

Härle T, Zeymer U, Schwarz AK, Lüers C, Hochadel M, Darius H, Kasper W, Hauptmann KE, Andresen D, Elsässer A.

Clin Res Cardiol. 2014 May;103(5):373-80. doi: 10.1007/s00392-014-0664-8.

PMID:
24435358
12.

Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the German TAVI Registry).

Bauer T, Linke A, Sievert H, Kahlert P, Hambrecht R, Nickenig G, Hauptmann KE, Sack S, Gerckens U, Schneider S, Zeymer U, Zahn R.

Am J Cardiol. 2014 Feb 1;113(3):518-21. doi: 10.1016/j.amjcard.2013.10.023.

PMID:
24342758
13.

Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve.

Schofer J, Colombo A, Klugmann S, Fajadet J, DeMarco F, Tchétché D, Maisano F, Bruschi G, Latib A, Bijuklic K, Weissman N, Low R, Thomas M, Young C, Redwood S, Mullen M, Yap J, Grube E, Nickenig G, Sinning JM, Hauptmann KE, Friedrich I, Lauterbach M, Schmoeckel M, Davidson C, Lefevre T.

J Am Coll Cardiol. 2014 Mar 4;63(8):763-8. doi: 10.1016/j.jacc.2013.10.013.

14.

Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery.

Hein R, Abdel-Wahab M, Sievert H, Kuck KH, Voehringer M, Hambrecht R, Sack S, Hauptmann KE, Senges J, Zahn R, Mudra H; German Transcatheter Aortic Valve Interventions Registry Investigators..

EuroIntervention. 2013 Aug 22;9(4):446-51. doi: 10.4244/EIJV9I4A73.

15.

Interventional treatment and outcome in elderly patients with stable coronary artery disease. Results from the German ALKK registry.

Rittger H, Hochadel M, Behrens S, Hauptmann KE, Zahn R, Mudra H, Brachmann J, Zeymer U.

Herz. 2014 Mar;39(2):212-8. doi: 10.1007/s00059-013-3822-2.

PMID:
23712825
16.

Intravascular ultrasound comparison of the self-expanding Sideguard stent in the side branch versus a balloon-expandable stent in the main vessel to assess mechanisms of acute lumen gain in bifurcation lesions.

Ma S, Maehara A, Hauptmann KE, Guagliumi G, Valsecchi O, Vassileva A, Appelman Y, Sangiorgi G, Prati F, Mintz GS.

Catheter Cardiovasc Interv. 2013 Nov 1;82(5):748-54. doi: 10.1002/ccd.24953.

PMID:
23592513
17.

Percutaneous closure of patent foramen ovale in cryptogenic embolism.

Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P; PC Trial Investigators..

N Engl J Med. 2013 Mar 21;368(12):1083-91. doi: 10.1056/NEJMoa1211716.

18.

Giant right coronary artery aneurysm in an adult male patient with non-ST myocardial infarction.

Halapas A, Lausberg H, Gehrig T, Friedrich I, Hauptmann KE.

Hellenic J Cardiol. 2013 Jan-Feb;54(1):69-76. Review.

19.

Impact of coronary artery disease on in-hospital mortality in patients with aortic valve disease. Results from the German ALKK registry.

Höllriegel R, Linke A, Hochadel M, Schuler G, Kerber S, Hambrecht R, Grube E, Hauptmann KE, Zahn R, Zeymer U, Senges J.

Herz. 2013 Jun;38(4):387-90. doi: 10.1007/s00059-012-3712-z.

PMID:
23324906
20.

Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry.

Zeymer U, Hochadel M, Hauptmann KE, Wiegand K, Schuhmacher B, Brachmann J, Gitt A, Zahn R.

Clin Res Cardiol. 2013 Mar;102(3):223-7. doi: 10.1007/s00392-012-0523-4.

PMID:
23179136
Items per page

Supplemental Content

Loading ...
Support Center